Joseph Mathew

Healthcare Global Enterprises

Papers

1

Total Citations

3

H-Index

1

About

Dr. Joseph Mathew is a pioneering colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques for locally advanced rectal cancer. His work centers on optimizing lateral pelvic lymph node dissection (LPLND), a technically demanding procedure critical for achieving complete oncological resection. In his landmark 2025 cohort study, Dr. Mathew compared laparoscopic and robotic approaches for LPLND, demonstrating that robotic surgery may offer superior perioperative outcomes and improved short-term oncological control in patients undergoing total mesorectal excision. This investigation, already garnering 3 citations, addresses a crucial gap in evidence for surgeons managing complex pelvic malignancies. By systematically evaluating morbidity and oncological adequacy between these platforms, Dr. Mathew provides actionable insights that guide surgical decision-making. His contributions are particularly significant given the rising adoption of robotic platforms in colorectal surgery. Through rigorous comparative effectiveness research, Dr. Mathew continues to shape best practices for high-risk rectal cancer patients, bridging the gap between technological innovation and measurable clinical benefit. His work stands as a vital resource for surgeons seeking to refine their approach to one of pelvic oncology's most challenging procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Laparoscopic Versus Robotic Lateral Pelvic Lymph Node Dissection in Locally‐Advanced Rectal Cancer: A Cohort Study Comparing Perioperative Morbidity and Short‐Term Oncological Outcomes
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Healthcare Global Enterprises

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago